These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10581742)

  • 1. [Myocardial diseases].
    Tanaka H
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1630-44. PubMed ID: 10581742
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonmalformative cardiovascular pathology in infants and children.
    Gilbert-Barness E; Barness LA
    Pediatr Dev Pathol; 1999; 2(6):499-530. PubMed ID: 10508875
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel cardiac beta-myosin heavy chain gene missense mutations (R869C and R870C) that cause familial hypertrophic cardiomyopathy.
    Anan R; Shono H; Tei C
    Hum Mutat; 2000 Jun; 15(6):584. PubMed ID: 10862102
    [No Abstract]   [Full Text] [Related]  

  • 4. Coexistence of gene mutations causing Fabry disease and Duchenne muscular dystrophy in a Japanese boy.
    Takenaka T; Sakuraba H; Hashimoto K; Fujino O; Fujita T; Tanaka H; Suzuki Y
    Clin Genet; 1996 May; 49(5):255-60. PubMed ID: 8832134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning disabilities in neuromuscular disorders: a springboard for adult life.
    Astrea G; Battini R; Lenzi S; Frosini S; Bonetti S; Moretti E; Perazza S; Santorelli FM; Pecini C
    Acta Myol; 2016 Oct; 35(2):90-95. PubMed ID: 28344438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results.
    Linthorst GE; Poorthuis BJ; Hollak CE
    J Am Coll Cardiol; 2008 May; 51(21):2082; author reply 2082-3. PubMed ID: 18498967
    [No Abstract]   [Full Text] [Related]  

  • 7. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of muscular limb-girdle dystrophy and mitochondrial myopathy.
    Calore EE; Cavaliere MJ; Wakamatsu A; Perez NM; Maeda MY; Russo DH
    Pathologica; 1994 Dec; 86(6):649-51. PubMed ID: 7617396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy and Anderson-Fabry disease: unravelling septal hypertrophy with T1-mapping CMR.
    Edwards NC; Teoh JK; Steeds RP
    Eur Heart J; 2014 Jul; 35(28):1896. PubMed ID: 24713641
    [No Abstract]   [Full Text] [Related]  

  • 10. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.
    Havndrup O; Christiansen M; Stoevring B; Jensen M; Hoffman-Bang J; Andersen PS; Hasholt L; Nørremølle A; Feldt-Rasmussen U; Køber L; Bundgaard H
    Eur J Heart Fail; 2010 Jun; 12(6):535-40. PubMed ID: 20498269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genotype-phenotype correlations in familial hypertrophic cardiomyopathy].
    Anan R; Niimura H; Tei C
    Nihon Rinsho; 2000 Jan; 58(1):134-40. PubMed ID: 10885301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropathic pain in a young female patient with Fabry's disease: a new mutation of the alpha-galactosidase A gene].
    Politei JM; Pagano MA; Dubrovsky A; Pereira F; Matte U; Burin M; Giugliani R
    Rev Neurol; 2005 Oct 16-31; 41(8):506-7. PubMed ID: 16224739
    [No Abstract]   [Full Text] [Related]  

  • 13. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Tesson F; Richard P; Charron P; Mathieu B; Cruaud C; Carrier L; Dubourg O; Lautié N; Desnos M; Millaire A; Isnard R; Hagege AA; Bouhour JB; Bennaceur M; Hainque B; Guicheney P; Schwartz K; Komajda M
    Hum Mutat; 1998; 12(6):385-92. PubMed ID: 9829907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New point mutation (R301X) of the alpha-galactosidase A gene causing Fabry disease.
    Kawanishi C; Osaka H; Inoue K; Onishi H; Yamada Y; Sugiyama N; Suzuki K; Hanihara T; Miyagawa T; Kimura S
    Hum Mutat; 1995; 6(2):186-7. PubMed ID: 7581405
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy.
    Gozal D
    Pediatr Pulmonol; 2000 Feb; 29(2):141-50. PubMed ID: 10639205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
    American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
    Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronologic study of signs of myocardiopathy in progressive muscular dystrophy].
    Barona Zamora P; Narbona García J; Alvarez Gómez MJ; Fidalgo Andrés ML; Sáenz de Buruaga J; Villa Elizaga I
    An Esp Pediatr; 1993 Feb; 38(2):173-7. PubMed ID: 8439105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.
    Nagao Y; Nakashima H; Fukuhara Y; Shimmoto M; Oshima A; Ikari Y; Mori Y; Sakuraba H; Suzuki Y
    Clin Genet; 1991 Mar; 39(3):233-7. PubMed ID: 1645238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
    Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
    Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.